Please rotate your device

YOUR ACTION PLAN FOR THE
MAXILLARY SINUS

Only PROPEL Contour combines mechanical spacing and localized drug delivery to the maxillary sinus, thereby maintaining sinus patency1

PROPEL Contour is an hourglass-shaped implant, 8 mm in nominal length, and indicated for the frontal and or maxillary sinus ostia1

Surgery + PROPEL Contour provides benefits following maxillary sinus surgery1,2

  • PROPEL Contour delivery success rate (primary endpoint) in maxillary sinuses was 95.2% (N=15)

  • 100% maxillary sinus ostial patency (secondary endpoint) was achieved at Day 30 (N=15)

  • Reduction in inflammation was observed at Day 30

Study Design: EXCEED was a 15-patient, prospective, single-arm, open-label feasibility trial. Patients were implanted with PROPEL Contour into the maxillary sinus ostia following sinus surgery with traditional instrumentation, balloon dilation, or a hybrid of both.1,3

For significant improvements to patient outcomes following sinus surgery, add PROPEL Contour to your battle for the maxillary sinus*

PRE-OP

Post-ess

4 months post-ess

ESS, endoscopic sinus surgery.

*Representative outcome of a single patient. Individual results may vary.

Optimal treatment following maxillary sinus surgery with a full arsenal of options including PROPEL Contour can help improve patient outcomes

GET PROPEL

Stay Informed

This site is intended for healthcare professionals in the United States

Stay Informed

References

  1. PROPEL Contour [Instructions for Use]. Menlo Park, CA: Intersect ENT; 2016.
  2. Data on file, Intersect ENT, Inc. EXCEED Clinical Study Report. Study #P500-0414, Doc #R 28019 Rev 1.0, March 28, 2016.
  3. ClinicalTrials.gov. Clinical Evaluation of Propel Nova Sinus Implant in Peripheral Sinus Ostia (EXCEED). https://clinicaltrials.gov/ct2/show/NCT02228720?term=exceed+propel&rank=1. Accessed June 20, 2019.